Clinical Trial Update: Multicenter Phase II Study of Transanal TME (taTME) [NA]

View source ↗

Summary

A multicenter Phase II study is evaluating transanal total mesorectal excision (taTME) for rectal cancer; the trial is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Rectal Cancer, Surgery | NA | Status: ACTIVE_NOT_RECRUITING